Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform (original) (raw)

References

  1. Berkower, I. 1996. The promise and pitfalls of monoclonal antibody therapeutics. Curr. Opin. Biotechnol. 7: 622–628.
    Article CAS PubMed Google Scholar
  2. Press, O.W., Eary, J.F., Appelbaum, F.R., Martin, P.J., Nelp, W.B., Glen, S., et al. 1995. Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autolo-gous stem cell transplantation for relapsed B cell lymphomas. Lancet 346: 336–340.
    Article CAS PubMed Google Scholar
  3. Riva, P., Arista, A., Tison, V., Sturiale, C., Franceschi, G., Spinelli, A. et al. 1994. Intralesional radio-immunotherapy of malignant gliomas. Cancer 73: 1076–1082.
    Article CAS PubMed Google Scholar
  4. Schneider-Gadicke, E. and Riethmüller, G. 1995. Prevention of manifest metastasis with monoclonal antibodies: a novel approach to immunotherapy of solid tumors. Eur. J. Cancer 31: 1326–1330.
    Article Google Scholar
  5. Maloney, D.G., Liles, T.M., Czerwinski, D.K., Waldichuk, C., Rosenberg, J., Grillo-Lopez, A., and Levy, R. 1994. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 84: 2457–2466.
    CAS PubMed Google Scholar
  6. Winter, G., Griffiths, A.D., Hawkins, R.E., and Hoogenboom, H.R. 1994. Making antibodies by phage display technology. Annu. Rev. Immunol. 12: 433–455.
    Article CAS PubMed Google Scholar
  7. Carter, P., Kelley, R.F., Rodrigues, M.L., Snedecor, B., Covarrubias, M., Velligan, M.D., et al. 1992. High level _Escherichia coli_expression and production of a bivalent humanized antibody fragment. Bio/Technology 10: 163–167.
    CAS Google Scholar
  8. Pack, P., Kujau, M., Schroeckh, U., Knüpfer, R., Wenderoth, R., Riesenberg, D., and Plückthun, A. 1993. Improved bivalent miniantibodies with identical avidity as whole antibodies produced by high cell density fermentation of Escherichia coli. Bio/Technology 11: 1271–1277.
    CAS Google Scholar
  9. Begent, R.H.J., Verhaar, M.J., Chester, K.A., Green, A.J., Napier, M.P., Hope-Stone, L.D., et al. 1996. Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library. Nature Medicine 2: 979–984.
    Article CAS PubMed Google Scholar
  10. Casey, J.L., Keep, P.A., Chester, K.A., Robson, L., Hawkins, R.E., and Begent, R.H. 1995. Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography. J. Immunol. Methods 179: 105–116.
    Article CAS PubMed Google Scholar
  11. Yokota, T., Milenic, D.E., Whitlow, M., and Schlom, J. 1992. Rapid tumor penetration of single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52: 3402–3408.
    CAS PubMed Google Scholar
  12. Pasqualini, R., Koivunen, E., and Ruoslahti, E. 1997. Alfa-v integrins as receptors for tumor targetin by circulating ligands. Nature Biotechnology 15: 542–546.
    Article CAS PubMed Google Scholar
  13. Kim, K.J., Li, B., Winer, J., Armanii, M., Gillett, N., Phillips, H.S., and Ferrara, N. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841–844.
    Article CAS PubMed Google Scholar
  14. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumathoid and other disease. Nature Med. 1: 27–31.
    Article CAS PubMed Google Scholar
  15. O'Reilly, M.S., Holmgren, L., Chen, C., and Folkman, J. 1996. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 2: 689–692.
    Article CAS PubMed Google Scholar
  16. Huang, H., Molema, G., King, S., Watkins, L., Edgington, T.S., and Thorpe, P.E. 1997. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor neo-vasculature. Science 275: 547–550.
    Article CAS PubMed Google Scholar
  17. Van den Hoff, A. 1988. Stromal involvement in malignant growth. Adv. Cancer Res. 50: 159–196.
    Article Google Scholar
  18. Risau, W. and Lemmon, V. 1988. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev. Biol. 125: 441–450.
    Article CAS PubMed Google Scholar
  19. Camemolla, B., Balza, E., Siri, A., Zardi, L., Nicotra, M.R., Bigotti, A., and Natali, P.G. 1989. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J. Cell Biol. 108: 1139–1148.
    Article Google Scholar
  20. Castellani, P., Viale, G., Dorcaratto, A., Nicolo', G., Kazmarek, J., Querze, G., and Zardi, L. 1994. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int. J. Cancer 59: 612–618.
    Article CAS PubMed Google Scholar
  21. Camemolla, B., Neri, D., Castellani, P., Leprini, A., Neri, G., Pini, A., et al. 1996. Phage antibodies with pan-species recognition of the oncofetal angiogenesis marker fibronectin ED-B domain. Int. J. Cancer 68: 397–405.
    Article Google Scholar
  22. Huston, J.S., Levinson, D., Mudgett, H.M., Tai, M.S., Novotny, J., Margolies, M.N., et al. 1988. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85: 5879–5883.
    Article CAS PubMed PubMed Central Google Scholar
  23. Bird, R.E., Hardman, K.D., Jacobson, J.W., Johnson, S., Kaufman, B.M., Lee, S.M., et al. 1988. Single-chain antigen-binding proteins. Science 242: 423–426.
    Article CAS PubMed Google Scholar
  24. Nissim, A., Hoogenboom, H.R., Tomlinson, I.M., Flynn, G., Midgley, C., Lane, D., and Winter, G. 1994. Antibody reagents from a ‘single-pot’ phage display library as immunochemical reagents. EMBO J. 13: 692–698.
    Article CAS PubMed PubMed Central Google Scholar
  25. Marks, J.D., Griffiths, A.D., Malmqvist, M., Clackson, T.P., Bye, J.M., and Winter, G. 1992. By-passing immunization: building high-affinity human antibodies by chain shuffling. Bio/Technology 10: 779–783
    CAS Google Scholar
  26. Low, N., Holliger, P., and Winter, G. 1996. Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain. J. Mol. Biol. 260: 359–368.
    Article CAS PubMed Google Scholar
  27. Griffiths, A.D., Williams, S.C., Hartley, O., Tomlinson, I.M., Waterhouse, P., Crosby, W.L., et al. 1994. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13: 3245–3260.
    Article CAS PubMed PubMed Central Google Scholar
  28. Vaughan, T.J., Williams, A.J., Pritchard, K., Osbourn, J.K., Pope, A.R., Earnshaw, J.C., et al. 1996. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nature Biotechnology 14: 309–314.
    Article CAS PubMed Google Scholar
  29. Folli, S., Westermann, P., Braichotte, D., Pelegrin, A., Weignieres, G., van der Bergh, H., and Mach, J.P. 1994. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res. 54: 2643–2649.
    CAS PubMed Google Scholar
  30. Neri, D., Prospero, T., Petrul, H., Winter, W., Browne, M., and Vanderpant, L. 1996. A multi-purpose high-sensitivity luminescence analyser (LUANA): use in gel electrophoresis. Bio/Techniques 20: 708–713.
    CAS Google Scholar
  31. Friedlander, M., Theesfeld, C.L., Sugita, M., Fruttiger, M., Thomas, M.A., Chang, S., and Cheresh, D.A. 1996. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. USA 93: 9764–9769.
    Article CAS PubMed PubMed Central Google Scholar
  32. Adams, G.P., McCartney, J.E., Tai, M.S., Oppermann, H., Huston, J.S., Stafford, W.F. III, et al. 1993. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB2 sincle-chain Fv. Cancer Res. 53: 4026–4034.
    CAS PubMed Google Scholar
  33. King, D.J., Turner, A., Farnsworth, A.P.H., Adair, J.R., Owens, R.J., Pedley, R.B., et al. 1994. Improved tumor targeting with chemically cross-linked recombinant antibody fragments. Cancer Res. 54: 6176–6185.
    CAS PubMed Google Scholar
  34. Hu, S., Shively, L., Raubitschek, A., Sherman, M., Williams, L.E., Wong, J.Y., et al. 1996. Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res. 56: 3055–3061.
    CAS PubMed Google Scholar
  35. Peters, J.H., Chen, G., and Hynes, R.O. 1996. Fibronectin isoform distribution in the mouse. II. Differential distribution of the alternatively spliced EIIIB, EIIIA, and V segments in the adult mouse. Cell Adhes. Commun. 4: 127–148.
    Google Scholar
  36. Bennett, V.D., Pallante, K.M., and Adams, S.L. 1991. The splicing pattern of fibronectin mRNA changes during chondrogenesis resulting in an unusual form of the mRNA in cartilage. J. Biol. Chem. 266: 5918–5924.
    CAS PubMed Google Scholar
  37. George, A.J., Jamar, F., Tai, M.S., Heelan, B.T., Adams, G.P., McCartney, J.E., et al. 1995. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetiurn-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide. Proc. Natl. Acad. Sci. USA 92: 8358–8362.
    Article CAS PubMed PubMed Central Google Scholar
  38. Liberatore, M., Neri, D., Neri, G., Pini, A., lurilli, A.P., Ponzo, F., et al. 1995. Efficient one-step direct labeling of recombinant antibodies with 99mTc. Eur. J. Nuclear Med. 22: 1326–1329.
    Article CAS Google Scholar
  39. Neri, D. and Zardi, L. 1997. New approaches to tumor targeting, in Therapy of malignancies with radio-conjugate monoclonal antibodies: present possibilities and future perspectives. Riva P. (ed.) Harwood Academic Publishers, Amsterdam, The Netherlands. In press.
    Google Scholar
  40. Padlan, E.A. 1994. Anatomy of the antibody molecule. Mol. Immunol. 31: 169–217.
    Article CAS PubMed Google Scholar
  41. Marks, J.D., Hoogenboom, H.R., Bonnert, T.P., McCafferty, J., Griffiths, A.D., and Winter, G. 1991. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222: 581–597.
    Article CAS PubMed Google Scholar
  42. Hoogenboom, H.R., Griffiths, A.D., Johnson, K.S., Chiswell, D.J., Hudson, P., and Winter, G. 1991. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucl. Acids Res. 19: 4133–4137.
    Article CAS PubMed PubMed Central Google Scholar
  43. Gibson, T.J. 1984. Studies on the Epstein-Barr virus genome. Ph.D. Thesis, University of Cambridge, Cambridge, UK.
  44. Jönsson, U., Fägerstam, L., Ivarsson, B., Johnsson, B., Karlsson, R., Lundh, K., et al. 1991. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. BioTechniques 11: 620–627.
    PubMed Google Scholar
  45. Neri, D., Petrul, H., Light, Y., Marais, R., Britton, K.E., Winter, G., and Creighton, A.M. 1996. Radioactive labeling of recombinant antibody fragments by phos-phorylation using human casein kinase II and [γ-32P]-ATP. Nature Biotechnology 14: 385–390.
    Article Google Scholar
  46. McCafferty, J., Griffiths, A.D., Winter, G., and Chiswell, D.J. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348: 552–554.
    Article CAS PubMed Google Scholar

Download references